CA9 and nonpapillary renal cell carcinoma: Notably, CAIX is expressedin over 90% of ccRCC cases, whereas its expression in other RCC subtypes(e.g., papillary RCC, chromophobe RCC) is minimal or absent, makingit an attractive target for ccRCC imaging and therapy.